Philips To Collaborate With Sichuan West China Hospital
This article was originally published in PharmAsia News
The chief technology officer of Philips, the third-largest medical imaging equipment maker, has disclosed that the company plans to form an alliance with West China Hospital in Sichuan province. The collaboration is said to include eight projects over seven years, and aims at helping physicians interpret medical images and diagnose diseases in the early stages. The partnership could raise Philips' status in China as West China Hospital represents one of the largest and oldest hospitals in the country. Currently, the over- $10 billion medical device market in China is continuing its rapid growth, a big draw for MNCs. (Click here for more - Chinese Language)
You may also be interested in...
One effect of Brexit is that the UK’s National Institute for Biological Standards and Control will have additional responsibilities from next year in terms of the independent batch testing and release of products such as vaccines and medicines derived from human blood and plasma in Great Britain.
Sun Pharma and its US Taro subsidiary have further criticized a recent CMS policy proposal that would see Medicare Part B drugs approved under the US hybrid 505(b)(2) pathway reimbursed at a lower rate applicable to multiple source products.
An advanced immunotherapy for recurrent glioblastoma and the first biosimilar version of Lucentis for age-related macular degeneration have also been submitted for review by the European Medicines Agency for potential pan-EU authorization.